MicroRNAs (miRNAs), a class of small, endogenous, noncoding RNA molecules, can serve as biomarkers for potential applications in cancer diagnosis, prognosis, and prediction due to its abnormal ...

Host biomarkers have recently gained interest as a complementary approach in infectious disease diagnostics, and both blood and nasal biomarkers have been proposed for diagnosis of respiratory ...

Objective IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments.

Instead, traditional biomarkers of PD-L1 expression and T-cell phenotyping did not reflect response trends and demonstrated significant heterogeneity inter- and intratumorally. Importantly, ...

Biomarkers for drug-induced immune reactions aid clinicians in diagnosing, risk-stratifying, and managing diseases. But the varied mechanisms and clinical presentations of drug hypersensitivity ...

Multigene panels for next-generation sequencing (NGS) are now US Food and Drug Administration (FDA)-approved in several tumor types. 1 In 2020 alone, 28 targeted therapies were approved by the FDA in ...

The selection of potential biomarkers based on the most correlated gene modules and differentially expressed genes. (A and B) The module–trait relationship plots shows that ME-greenyellow module and ...

Title: Taurine is not a biomarker for aging after all. Author: * Send Email To: Enter the valid email address. * Add Comment To Email: Enter the comment.

"Identifying reliable biomarkers to predict the onset and progression of aging and functional decline would be a major breakthrough, enabling more effective, personalized strategies to maintain ...

The whole-body MRI data of 27,518 NAKO participants aged between 19 and 74 were analyzed. 21.8% reported chronic back pain. Using MRI-based, AI-supported muscle segmentation, the back muscles were ...